Membrane and Capillary Components of Lung Diffusion in Infants with Bronchopulmonary Dysplasia

被引:24
|
作者
Chang, Daniel V. [1 ]
Assaf, Santiago J. [1 ]
Tiller, Christina J. [1 ]
Kisling, Jeffrey A. [1 ]
Tepper, Robert S. [1 ]
机构
[1] Indiana Univ, Dept Pediat Pulmonol, James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA
基金
美国国家卫生研究院;
关键词
bronchopulmonary dysplasia; infants; lung growth; pulmonary diffusion capacity; POSTNATAL-DEVELOPMENT; MORPHOMETRIC-ANALYSIS; BLOOD-VOLUME; GROWTH; CAPACITY;
D O I
10.1164/rccm.201506-1219OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Autopsied lungs of infants with bronchopulmonary dysplasia (BPD) demonstrate impaired alveolar development with larger and fewer alveoli, which is consistent with our previous physiologic findings of lower pulmonary diffusing capacity of the lung for carbon monoxide (DLCO) in infants and toddlers with BPD compared with healthy controls born at full term (FT). However, it is not known whether the decreased DLCO in infants with BPD results from a reduction in both components of DLCO: pulmonary membrane diffusing capacity (D-M) and Vc. Objectives: We hypothesized that impairment of alveolar development in BPD results in a decrease in both D-M and Vc components of DLCO but that the D-M/Vc ratio would not differ between the BPD and FT groups. Methods: DLCO was measured under conditions of room air and high inspired oxygen (90%), which enabled D-M and Vc to be calculated. Measurements and Main Results: D-M and Vc increased with increasing body length; however, infants with BPD had significantly lower D-M and Vc than FT subjects after adjustment for race, sex, body length, and corrected age. In contrast to D-M and Vc, the D-M/Vc ratio remained constant with increasing body length and did not differ for infants with BPD and FT subjects. Conclusions: Our findings are consistent with infants with BPD having impaired alveolar development with fewer but larger alveoli, as well as a reduced Vc.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 50 条
  • [41] DELAYED IMMUNIZATION OF INFANTS WITH BRONCHOPULMONARY DYSPLASIA
    SHELTON, C
    JENKINS, MB
    GONZALEZ, F
    CARLSTROM, J
    MOLTENI, RA
    PEDIATRIC RESEARCH, 1989, 25 (04) : A105 - A105
  • [42] Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia
    DeMauro, Sara B.
    PEDIATRIC PULMONOLOGY, 2021, 56 (11) : 3509 - 3517
  • [43] NEBULIZED FUROSEMIDE IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
    RASTOGI, A
    LUAYON, M
    AJAYI, OA
    PILDES, RS
    JOURNAL OF PEDIATRICS, 1994, 125 (06): : 976 - 979
  • [44] Oxygen consumption in infants with bronchopulmonary dysplasia
    Rozé, JC
    Darmaun, D
    Gaultier, C
    PEDIATRIC PULMONOLOGY, 1997, : 172 - 173
  • [45] MINIMIZING BRONCHOPULMONARY DYSPLASIA IN VLBW INFANTS
    BOYNTON, BR
    MANNINO, FL
    RANDEL, RC
    MERRITT, TA
    COEN, RW
    EDWARDS, D
    GLUCK, L
    JOURNAL OF PEDIATRICS, 1984, 104 (06): : 962 - 963
  • [46] VASOPRESSIN EXCESS IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
    HAZINSKI, TA
    BLALOCK, WA
    ENGELHARDT, B
    PEDIATRIC RESEARCH, 1986, 20 (04) : A431 - A431
  • [47] Weaning oxygen in infants with bronchopulmonary dysplasia
    Everitt, Lucy H.
    Awoseyila, Adejumoke
    Bhatt, Jayesh M.
    Johnson, Mark J.
    Vollmer, Brigitte
    Evans, Hazel J.
    PAEDIATRIC RESPIRATORY REVIEWS, 2021, 39 : 82 - 89
  • [48] Volumetric Capnography in Infants with Bronchopulmonary Dysplasia
    Fouzas, Sotirios
    Haecki, Christoph
    Latzin, Philipp
    Proietti, Elena
    Schulzke, Sven
    Frey, Urs
    Delgado-Eckert, Edgar
    JOURNAL OF PEDIATRICS, 2014, 164 (02): : 283 - +
  • [49] Systemic Hypertension in Infants with Bronchopulmonary Dysplasia
    Starr, Michelle C.
    Wilson, Amy C.
    CURRENT HYPERTENSION REPORTS, 2022, 24 (06) : 193 - 203
  • [50] Systemic Hypertension in Infants with Bronchopulmonary Dysplasia
    Michelle C. Starr
    Amy C. Wilson
    Current Hypertension Reports, 2022, 24 : 193 - 203